Trials / Completed
CompletedNCT00913419
To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets
Bioavailability of Cyclobenzaprine HCl Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Cyclobenzaprine HCl tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclobenzaprine HCl Tablets 10 mg, Cord Laboratories | |
| DRUG | Cyclobenzaprine HCl Tablets 10 mg, Merck Sharp & Dohme |
Timeline
- Start date
- 1988-11-01
- Primary completion
- 1988-12-01
- Completion
- 1988-12-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913419. Inclusion in this directory is not an endorsement.